Nicholas Hollmeyer Lynton Sells 5,936 Shares of Cardlytics, Inc. (NASDAQ:CDLX) Stock

by · The Cerbat Gem

Cardlytics, Inc. (NASDAQ:CDLX – Get Free Report) insider Nicholas Hollmeyer Lynton sold 5,936 shares of the company’s stock in a transaction on Wednesday, October 2nd. The stock was sold at an average price of $3.08, for a total value of $18,282.88. Following the transaction, the insider now directly owns 85,445 shares in the company, valued at $263,170.60. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

Cardlytics Stock Performance

NASDAQ:CDLX opened at $3.29 on Friday. The company has a current ratio of 1.77, a quick ratio of 1.77 and a debt-to-equity ratio of 1.01. The company has a market capitalization of $160.50 million, a P/E ratio of -0.74 and a beta of 1.67. The firm has a 50-day moving average price of $4.35 and a two-hundred day moving average price of $8.52. Cardlytics, Inc. has a twelve month low of $2.89 and a twelve month high of $20.52.

Cardlytics (NASDAQ:CDLX – Get Free Report) last issued its quarterly earnings data on Wednesday, August 7th. The company reported ($0.09) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.21) by $0.12. Cardlytics had a negative net margin of 50.21% and a negative return on equity of 17.96%. The business had revenue of $69.64 million during the quarter, compared to analysts’ expectations of $75.39 million. During the same period last year, the company posted ($0.57) EPS. The company’s revenue was down 9.2% on a year-over-year basis. As a group, research analysts expect that Cardlytics, Inc. will post -1.72 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities research analysts have commented on CDLX shares. Lake Street Capital lowered shares of Cardlytics from a “buy” rating to a “hold” rating and decreased their target price for the stock from $18.00 to $5.00 in a research report on Thursday, August 8th. Needham & Company LLC downgraded shares of Cardlytics from a “buy” rating to a “hold” rating in a report on Thursday, August 8th. Northland Capmk cut shares of Cardlytics from a “strong-buy” rating to a “hold” rating in a report on Friday, August 16th. Craig Hallum downgraded shares of Cardlytics from a “buy” rating to a “hold” rating in a research report on Thursday, August 8th. Finally, Northland Securities cut Cardlytics from an “outperform” rating to a “market perform” rating and lowered their price target for the stock from $7.00 to $5.00 in a report on Friday, August 16th. One research analyst has rated the stock with a sell rating and five have given a hold rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $7.50.

Check Out Our Latest Stock Analysis on Cardlytics

Hedge Funds Weigh In On Cardlytics

Institutional investors have recently made changes to their positions in the stock. Renaissance Technologies LLC lifted its position in shares of Cardlytics by 711.9% in the second quarter. Renaissance Technologies LLC now owns 351,035 shares of the company’s stock valued at $2,882,000 after acquiring an additional 307,800 shares in the last quarter. Kent Lake Capital LLC purchased a new position in Cardlytics in the 1st quarter valued at about $3,622,000. Perbak Capital Partners LLP acquired a new stake in shares of Cardlytics during the 1st quarter worth about $2,348,000. General Equity Holdings LP grew its holdings in shares of Cardlytics by 31.0% during the fourth quarter. General Equity Holdings LP now owns 624,058 shares of the company’s stock worth $5,748,000 after buying an additional 147,843 shares in the last quarter. Finally, Blackstone Inc. purchased a new stake in shares of Cardlytics during the first quarter worth about $2,029,000. 68.10% of the stock is owned by institutional investors and hedge funds.

About Cardlytics

(Get Free Report)

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.

See Also